Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Video Abstracts
Reviews
Reviews
View all reviews ...
Review Series
Microbiome in Health and Disease (Feb 2025)
Substance Use Disorders (Oct 2024)
Clonal Hematopoiesis (Oct 2024)
Sex Differences in Medicine (Sep 2024)
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
0 Articles
181 Posts
No articles were found with this tag.
← Previous
1
2
…
17
18
19
Next →
PSD-95 expression controls
L
-DOPA dyskinesia through dopamine D1 receptor trafficking
Erwan Bezard and Laurent Groc of the University of Bordeaux discuss the effects of the post-synaptic density protein PSD-95 on the development of levodopa-induced dyskinesia.
Published October 8, 2012
Video Abstracts
← Previous
1
2
…
17
18
19
Next →
Advertisement
